Indegene

What does it take to build resilient, high-performing medical writing teams today? In this blog, industry leaders from AbbVie and Merck share practical strategies for strengthening resourcing models in medical writing groups. From structured rotations that deepen document expertise to experience grids that transform project staffing, and mentoring approaches that build future-ready talent. If you're looking to balance quality, efficiency, and team development, this is a must-read.

Pharmaceutical labels may serve the same purpose globally. But they are structured, interpreted, and regulated very differently. From section formats to safety communication requirements, each market brings its own nuances. Without a clear approach to managing these differences, consistency becomes difficult to sustain. This whitepaper provides a comparative view of major markets and highlights how organizations can align core information while adapting to regional expectations. Understand what drives variation, and how to manage it effectively.

AI can scale patient communication at unprecedented speed. But without the patient voice, it risks scaling the wrong message. In this blog, we explore what’s at stake: • When patient-friendly content becomes easier to generate than to validate • Why cultural nuance cannot be treated as optional • How AI models may unintentionally widen health disparities • Why “Nothing about us without us” must remain the standard

GenAI pilots generate excitement. But enterprise value demands discipline. Merck’s journey shows that moving from experimentation to scaled impact isn’t about deploying more tools. It’s about redesigning workflows end-to-end, embedding governance early, and building user confidence alongside capability. In regulated, knowledge-driven environments, quality and trust determine whether AI initiatives stall or scale. Because production isn’t just about generating output. It’s about generating value. Read the blog to explore what it really takes to move from pilots to enterprise impact.

Consent must not be an afterthought. As privacy and personalization expectations grow, fragmented consent processes are holding life sciences organizations back. Discover how you can turn consent from a compliance checkbox into a strategic advantage powered by strong operations, centralized governance, and smart automation.

AI won’t fix broken metadata. In pharma marketing, we invest in platforms, personalization engines, and analytics. But when tagging and taxonomy are inconsistent, campaigns stall, attribution blurs and teams fall back on manual fixes. That’s not a technology problem. It’s an execution gap. Learn why tagging and taxonomy must be treated as a strategic capability, with governance, ownership and operational discipline.